100 related articles for article (PubMed ID: 18798138)
21. [The skin--an immunocompetent organ].
Simon JC
Fortschr Med; 1994 Jul; 112(20-21):293-5. PubMed ID: 7927103
[TBL] [Abstract][Full Text] [Related]
22. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
Bergfelt L
Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
[TBL] [Abstract][Full Text] [Related]
23. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
24. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
Rosenberg AS; Katz SI; Singer A
J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
[TBL] [Abstract][Full Text] [Related]
25. Asialo GM1 positive CD8+ T cells induce skin allograft rejection in the absence of the secondary lymphoid organs.
Yamanokuchi S; Ikai I; Nishitai R; Matsushita T; Sugimoto S; Shiotani T; Yamaoka Y
J Surg Res; 2005 Nov; 129(1):57-63. PubMed ID: 16140338
[TBL] [Abstract][Full Text] [Related]
26. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion.
Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M
Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116
[TBL] [Abstract][Full Text] [Related]
27. A new vascularized skin transplant model in rats.
Ren B; Sun J; Painter DM; Sheil AG
Microsurgery; 1999; 19(7):326-9. PubMed ID: 10586197
[TBL] [Abstract][Full Text] [Related]
28. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
Peeler JS; Niederkorn JY
J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
[TBL] [Abstract][Full Text] [Related]
29. Vascularized bone-marrow allotransplantation in rats prolongs the survival of simultaneously grafted alloskin.
Tsuchida Y; Usui M; Uede T
J Reconstr Microsurg; 2002 May; 18(4):289-94. PubMed ID: 12022034
[TBL] [Abstract][Full Text] [Related]
30. In vitro production and transplantation of immunologically active skin equivalents.
Rouabhia M
Lab Invest; 1996 Oct; 75(4):503-17. PubMed ID: 8874382
[TBL] [Abstract][Full Text] [Related]
31. Advances in the development of experimental composite tissue transplantation models.
Siemionow M; Klimczak A
Transpl Int; 2010 Jan; 23(1):2-13. PubMed ID: 19719468
[TBL] [Abstract][Full Text] [Related]
32. Corneal allografts induce cytotoxic T cell but not delayed hypersensitivity responses in mice.
Peeler J; Niederkorn J; Matoba A
Invest Ophthalmol Vis Sci; 1985 Nov; 26(11):1516-23. PubMed ID: 2414248
[TBL] [Abstract][Full Text] [Related]
33. Cutting edge: virus selectively primes human langerhans cells for CD70 expression promoting CD8+ T cell responses.
van der Aar AM; de Groot R; Sanchez-Hernandez M; Taanman EW; van Lier RA; Teunissen MB; de Jong EC; Kapsenberg ML
J Immunol; 2011 Oct; 187(7):3488-92. PubMed ID: 21880979
[TBL] [Abstract][Full Text] [Related]
34. Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody.
Cavazzana-Calvo M; Sarnacki S; Haddad E; De Coene C; Calise D; Yvon E; Cerf-Bensussan N; Fischer A
Transplantation; 1995 Jun; 59(11):1576-82. PubMed ID: 7778173
[TBL] [Abstract][Full Text] [Related]
35. Cultured epithelium allografts: Langerhans cell and Thy-1+ dendritic epidermal cell depletion effects on allograft rejection.
Rouabhia M; Germain L; Bélanger F; Auger FA
Transplantation; 1993 Aug; 56(2):259-64. PubMed ID: 8102819
[TBL] [Abstract][Full Text] [Related]
36. A comparison of immune response to nerve and skin allografts.
Trumble T; Gunlikson R; Parvin D
J Reconstr Microsurg; 1993 Sep; 9(5):367-72. PubMed ID: 8301635
[TBL] [Abstract][Full Text] [Related]
37. Composite vascularized skin/bone transplantation models for bone marrow-based tolerance studies.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Siemionow M
Ann Plast Surg; 2006 Mar; 56(3):295-300. PubMed ID: 16508361
[TBL] [Abstract][Full Text] [Related]
38. Strategies to develop chimerism in vascularized skin allografts across MHC barrier.
Demir Y; Ozmen S; Klimczak A; Mukherjee AL; Siemionow MZ
Microsurgery; 2005; 25(5):415-22. PubMed ID: 16025439
[TBL] [Abstract][Full Text] [Related]
39. The Langerhans cell.
Wolff K; Stingl G
J Invest Dermatol; 1983 Jun; 80 Suppl():17s-21s. PubMed ID: 6343515
[TBL] [Abstract][Full Text] [Related]
40. Permanent acceptance of both cardiac and skin allografts using a mild conditioning regimen for the induction of stable mixed chimerism in mice.
van Pel M; Hilbrands L; Smits D; van Breugel DW; van Eck M; Boog CJ
Transpl Immunol; 2003; 11(1):57-63. PubMed ID: 12727476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
